Residency Program Overview

Established in 2005, the Novo Nordisk Multidisciplinary Pharm.D. Residency Program provides pharmacy professionals with hands-on experience in various functional areas in the pharmaceutical industry. During this unique 24-month program, the Industry Practice Resident will gain 6 months of experience in Drug Information and 6 months in Regulatory Affairs. During the 2nd year of the program, the resident will spend time in other functional areas within Novo Nordisk Inc. Based upon personal interest and business needs, the resident will be assigned to additional rotations in two of the following departments: Diabetes Medical and Scientific Affairs or Clinical Affairs - Biopharmaceuticals, Diabetes Brand Marketing, Diabetes Market Shaping or Professional Education Services.

The intent of the program is to provide residents with the skills needed to pursue a career within the pharmaceutical industry where their education and experience can make a significant contribution to satisfying customer needs and achieving company goals.

The resident will report to the Residency Program Director throughout the 24-month program and will also have a reporting relationship with a manager in the respective functional areas during each 6-month rotation. The resident’s goals will be set at the beginning of each rotation and performance reviews will be conducted at the conclusion of each rotation. At the end of the program, the resident will be issued a certificate of completion.